BXRX Market Cap History
Below is a table of the BXRX market cap history going back to 11/14/2019:

Date BXRX Market Cap

Also see: BXRX Shares Outstanding History
and BXRX YTD Return
BXRX Historical Market Cap:
-11.44% CAGR
BXRX Historical Market Cap: +-11.44% CAGR

Mouse over chart for data details
Baudax Bio is a pharmaceutical company primarily focused on developing and commercializing products for hospital and related acute care settings. Co.'s main product candidate is a proprietary injectable form of meloxicam, a once a day, preferential COX-2 inhibitor that possesses analgesic, anti-inflammatory, and antipyretic activities. Co.'s other early-stage product candidates include; intermediate and short-acting neuromuscular blocking agents, which are used as muscle paralyzing agents to facilitate intubation and surgery; and accompanying reversal agents, DEX-IN, which is a selective alpha-2 adrenergic agonist that has demonstrated sedative, analgesic and anxiolytic properties. We show 8 historical shares outstanding datapoints in our BXRX shares outstanding history coverage, used to compute BXRX market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing BXRX market cap history over the course of time is important for investors interested in comparing BXRX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of BXRX versus a peer is one thing; comparing BXRX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like BXRX can fluctuate over the course of history. With this page we aim to empower investors researching BXRX by allowing them to research the BXRX market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree BXRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Baudax Bio (BXRX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

CABA Market Cap History
CADL Market Cap History
CAH Market Cap History
CALA Market Cap History
CAPR Market Cap History
CARA Market Cap History
CASI Market Cap History
CASM Market Cap History
CATB Market Cap History
CATS Market Cap History
More Healthcare companies »


BXRX Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.